From Bench to Humans: Formulation Development of a Poorly Water Soluble Drug to Mitigate Food Effect
Journal Title: AAPS PharmSciTech - Year 2014, Vol 15, Issue 2
Abstract
This study presents a formulation approach that was shown to mitigate the dramatic food effect observed for a BCS Class II drug. In vitro (dissolution), in vivo (dog), and in silico (GastroPlus®) models were developed to understand the food effect and design strategies to mitigate it. The results showed that such models can be used successfully to mimic the clinically observed food effect. GastroPlus® modeling showed that food effect was primarily due to the extensive solubilization of the drug into the dietary lipid content of the meal. Several formulations were screened for dissolution rate using the biorelevant dissolution tests. Surfactant type and binder amount were found to play a significant role in the dissolution rate of the tablet prototypes that were manufactured using a high-shear wet granulation process. The performance of the lead prototypes (exhibiting best in vitro dissolution performance) was tested in dogs and human subjects. A new formulation approach, where vitamin E TPGS was included in the tablet formulation, was found to mitigate the food effect in humans.
Authors and Affiliations
Preetanshu Pandey, Rhye Hamey, Dilbir S. Bindra, Zongyun Huang, Neil Mathias, Timothy Eley, John Crison, Brian Yan, Robert Perrone, Chandra Vemavarapu
Size Control in the Nanoprecipitation Process of Stable Iodine (127I) Using Microchannel Reactor—Optimization by Artificial Neural Networks
For the present study, potassium iodide (KI) (Merck chemicals, Germany), Tween 80 (polysorbate 80) (Sigma-Aldrich, USA), and absolute ethyl alcohol (ethanol) 99/6% (V/V) (Jahan Alkol Teb Arak co. (JATA), Iran) were used...
Effervescence Assisted Fusion Technique to Enhance the Solubility of Drugs
The solubility of five poorly soluble drugs was enhanced by using an effervescence assisted solid dispersion (EASD) technique. EASDs were prepared by using modified fusion method. Drug and hydrophilic carrier were melted...
Retraction Note: Meloxicam Taste-Masked Oral Disintegrating Tablet with Dissolution Enhanced by Ion Exchange Resins and Cyclodextrin
The online version of the original article can be found at 10.1208/s12249-013-0001-y.
Probucol Release from Novel Multicompartmental Microcapsules for the Oral Targeted Delivery in Type 2 Diabetes
In previous studies, we developed and characterised multicompartmental microcapsules as a platform for the targeted oral delivery of lipophilic drugs in type 2 diabetes (T2D). We also designed a new microencapsulated for...
Antitumor Activity of DMAKO-05, a Novel Shikonin Derivative, and Its Metabolism in Rat Liver Microsome
The antitumor activity of shikonin derivatives is largely dependent on the generation of superoxide radicals and the alkylation activity of their naphthoquinone moiety. However, our recent study showed that 1,4-dioxime-5...